La chaîne d'options affiche les données clés des options sur actions de WonderFi Techs à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour WonderFi Techs..

WonderFi Techs (OTC:WONDF) Stock, Chaîne d'Options

WonderFi Technologies Inc is a technology company with the mission of creating digital access through its platforms. It operates in three segments: Trading, Payments, and Corporate. The Trading segment, comprising Bitbuy, Coinsquare, and CoinSmart crypto exchange platforms, generates the majority of the company's revenue.

WONDERFI TECHNOLOGIES INC by Wonderfi Technologies Inc.

WonderFi Technologies Inc

BioCardia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCDA#NASDAQ">BCDA</a>) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.39) by 51.28 percent. This is a 56.3 percent increase over losses of $(1.35) per share from the same period last year.

Earnings

Earnings Misses

News

BCDA

BioCardia Q1 EPS $(0.59) Misses $(0.39) Estimate

Conifer Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNFR#NASDAQ">CNFR</a>) reported quarterly losses of $(0.30) per share. This is a 372.73 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $10.31 million in sales this quarter. This is a 38.92 percent decrease over sales of $16.89 million the same period last year.

CNFR

Conifer Holdings Q1 Adj. EPS $(0.30) Down From $0.11 YoY, Sales $10.31M Down From $16.89M YoY

WIIM

BOOT

Boot Barn Holdings shares are trading higher after the company issued Q1 guidance with its midpoint above estimates and announced a $200 million share repurchase program.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

Canaan For April Mined 87 Bitcoins

Zentalis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZNTL#NASDAQ">ZNTL</a>) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.63) by 6.35 percent. This is a 578.57 percent decrease over earnings of $0.14 per share from the same period last year.

ZNTL

Zentalis Pharma Q1 EPS $(0.67) Misses $(0.63) Estimate

DXC Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.77 by 9.09 percent. This is a 13.4 percent decrease over earnings of $0.97 per share from the same period last year. The company reported quarterly sales of $3.17 billion which beat the analyst consensus estimate of $3.13 billion by 1.16 percent. This is a 6.41 percent decrease over sales of $3.39 billion the same period last year.

Earnings Beats

DXC Technology Q4 Adj. EPS $0.84 Beats $0.77 Estimate, Sales $3.17B Beat $3.13B Estimate

CRWV

CoreWeave Q1 Adj. EPS $(0.599) May Not Compare To $(0.12) Estimate

Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) FY2025 Revenue expected to be more than $60.00M vs $67.92M Est

Guidance

ELVA

Electrovaya FY2025  Revenue expected to be more than $60.00M vs $67.92M Est

GCT Semiconductor Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GCTS#NYSE">GCTS</a>) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.10) by 50 percent. This is a 600 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $496.00 thousand which missed the analyst consensus estimate of $1.87 million by 73.53 percent. This is a 84.81 percent decrease over sales of $3.27 million the same period last year.

GCTS

GCT Semiconductor Hldgs Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $496.00K Miss $1.87M Estimate

Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) is looking for Q1 GAAP EPS of $1.44-$1.52 vs $1.44 analyst estimate. sees sales of $483.000 million-$491.000 million vs $486.49 million analyst estimate.

Boot Barn Holdings Sees Q1 GAAP EPS $1.44-$1.52 vs $1.44 Est; Sees Sales $483.000M-$491.000M vs $486.49M Est

Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) is looking for FY2026 GAAP EPS of $5.50-$6.40 vs $6.24 analyst estimate. sees sales of $2.070 billion-$2.150 billion vs $2.17 billion analyst estimate.

Boot Barn Holdings Sees FY2026 GAAP EPS $5.50-$6.40 vs $6.24 Est; Sees Sales $2.070B-$2.150B vs $2.17B Est

Electrovaya (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELVA#NASDAQ">ELVA</a>) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.03 by 33.33 percent. This is a 200 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $15.02 million which missed the analyst consensus estimate of $15.95 million by 5.84 percent. This is a 40.42 percent increase over sales of $10.70 million the same period last year.

Electrovaya Q2 EPS $0.02 Misses $0.03 Estimate, Sales $15.02M Miss $15.95M Estimate

Biotech

General

SILO

Silo Pharma Engages Veloxity Labs For Bioanalytical IND-Enabling Study For Novel Intranasal PTSD Therapy, SPC-15

The Beachbody Company, Inc. Class A Common Stock

BODI

The Beachbody Company shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance with its midpoint above estimates.

Maze Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAZE#NASDAQ">MAZE</a>) reported quarterly losses of $(1.15) per share. This is a 91.73 percent increase over losses of $(13.91) per share from the same period last year.

MAZE

Maze Therapeutics Q1 EPS $(1.15) Up From $(13.91) YoY

Acuren Uplists To NYSE

Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) stock traded lower on Wednesday. <a href="https://www.cnbc.com/2025/05/14/chinese-robotaxi-operator-ponyai-reports-first-fire-no-injuries.html">CNBC </a>reported that one of the company&#8217;s robotaxis <a href="https://www.benzinga.com/25/05/45416148/pony-ai-shares-rise-after-report-of-confidential-hong-kong-ipo-to-fund-robotaxi-expansion">caught on fire.</a>
The Details: The incident occurred in Beijing, with no passengers involved. This marks the first time one of Pony AI&#8217;s robotaxis has caught fire.
Pony AI said one of its fully autonomous vehicles was found to have an abnormal status in Beijing around 9:30 a.m. local time on May 13. Service workers arrived within two minutes, but the vehicle caught fire during the response.
The company has not announced the cause of the fire.
PONY Price Action: PONY AI shares are down 5.68% at $16.93 on Wednesday, according to data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro.</a>
See Also: • <a href="https://www.benzinga.com/25/05/45417156/nvidia-amd-stocks-climb-as-trump-plans-to-ease-ai-chip-export-rules">Nvidia, AMD And Other Chip Stocks Gain As Trump Plans To Ease AI Chip Export Rules</a>
Photo: via Shutterstock

Movers

PONY

Pony AI Stock Is Sliding Wednesday: What's Going On?

Challenge Study measured safety, efficacy against infection and symptomatic disease as well as viral shedding
Machine learning analyses identified statistically significant correlates of protection and will be incorporated into the development of Vaxart's second-generation norovirus vaccine candidate, which is being evaluated in a Phase 1 clinical trial

VXRT

Vaxart Publishes Complete Data From Phase 2b Challenge Study Of First-Generation Oral Pill Norovirus Vaccine Candidate In Science Translational Medicine

AGMH

AGM Group shares are trading lower after the company announced a 50-for-1 share consolidation.

AYTU

Aytu BioPharma shares are trading higher after the company reported Q3 financial results and beat its EPS and revenue estimates.

Lowering Of Rates Spurs Investment In Bitcoin And Other Digital Assets

Continued Crypto Adoption Pushes Shares Of This Crypto Trading Platform Higher

Press Releases

Alset AI Acquires Tokens of World's Largest Decentralized Artificial Intelligence Computing Network

Riot Platforms Announces Changes to Its Board of Directors and Provides Update on Formal Evaluation of AI/HPC Uses

BTCS Unveils Strategic Partnership with Figment and WonderFi Leading its Staker Protection Plan

BTCS Highlights Ethereum's Successful Pectra Upgrade

$BTC

ALSCF

BTCS

LINE

PCOR

RIOT

TSX:WNDR

TSXV:GPUS

WONDF

WonderFi Techs

Screenshot 2025-02-19 at 6.51.20 PM

BTCS, Figment And WonderFi To Kick Off Pilot Program For New Staker Protection Plan In March

Screenshot 2024-11-01 at 10.00.01 PM

Interview

Screenshot 2024-03-15 at 5.33.52 PM

CEO Of Leading Canadian Cryptocurrency Business Excited About The Future Of The Market

Comments

WonderFi Techs

WonderFi Techs (WONDF) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL